Fumio Umeda

2.1k total citations
78 papers, 1.4k citations indexed

About

Fumio Umeda is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Fumio Umeda has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in Fumio Umeda's work include Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (14 papers) and Pancreatic function and diabetes (12 papers). Fumio Umeda is often cited by papers focused on Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (14 papers) and Pancreatic function and diabetes (12 papers). Fumio Umeda collaborates with scholars based in Japan, United States and Canada. Fumio Umeda's co-authors include Hajime Nawata, Teruaki Yamauchi, Toyoshi Inoguchi, Makoto Kunisaki, George L. King, Ryoichi Takayanagi, Sven–Erik Bursell, Keizo Ohnaka, Hiroshi Ibayashi and Jun Watanabe and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Diabetes.

In The Last Decade

Fumio Umeda

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Umeda Japan 20 448 397 350 286 247 78 1.4k
P. Fumelli Italy 19 379 0.8× 302 0.8× 237 0.7× 248 0.9× 173 0.7× 52 1.1k
PP Nawroth Germany 15 378 0.8× 344 0.9× 279 0.8× 167 0.6× 116 0.5× 44 1.3k
Thomas Quaschning Germany 23 384 0.9× 674 1.7× 431 1.2× 368 1.3× 633 2.6× 54 2.1k
G L King United States 12 457 1.0× 500 1.3× 823 2.4× 218 0.8× 275 1.1× 14 2.1k
Teruaki Yamauchi Japan 11 452 1.0× 636 1.6× 574 1.6× 233 0.8× 455 1.8× 22 1.8k
Noriko Takahara Japan 15 372 0.8× 512 1.3× 781 2.2× 223 0.8× 363 1.5× 26 1.9k
Koji Kuboki Japan 10 440 1.0× 371 0.9× 505 1.4× 212 0.7× 276 1.1× 22 1.5k
Sachiko Hattori Japan 21 420 0.9× 411 1.0× 637 1.8× 274 1.0× 289 1.2× 38 1.8k
Domenico De Cesare Italy 18 377 0.8× 173 0.4× 332 0.9× 282 1.0× 370 1.5× 22 1.9k
Antonio J. Cayatte United States 12 241 0.5× 887 2.2× 369 1.1× 301 1.1× 650 2.6× 17 1.8k

Countries citing papers authored by Fumio Umeda

Since Specialization
Citations

This map shows the geographic impact of Fumio Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Umeda more than expected).

Fields of papers citing papers by Fumio Umeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Umeda. The network helps show where Fumio Umeda may publish in the future.

Co-authorship network of co-authors of Fumio Umeda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Umeda. A scholar is included among the top collaborators of Fumio Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Umeda. Fumio Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoguchi, Toyoshi, Mayumi Yamato, Michikazu Nakai, et al.. (2019). Serum bilirubin level is a strong predictor for disability in activities in daily living (ADL) in Japanese elderly patients with diabetes. Scientific Reports. 9(1). 7069–7069. 15 indexed citations
2.
Kitamura, Yuji, Hiroshi Shiga, Kenji Ikeda, et al.. (2011). Effectiveness of systemic chemotherapy using CBDCA and 5-FU in a case of hepatocellular carcinoma with metastases to the lung. Kanzo. 52(1). 42–49.
3.
Hashimoto, Toshihiko, Minako Imamura, Takashi Etoh, et al.. (2002). Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells. Journal of Diabetes and its Complications. 16(1). 81–86. 4 indexed citations
4.
YOSHIKAWA, Hiroyasu, et al.. (2002). Glucosamine-induced β-cell Dysfunction: A Possible Involvement of Glucokinase or Glucose-transporter Type 2. Pancreas. 24(3). 228–234. 16 indexed citations
5.
Hata, Yasuaki, Allen C. Clermont, Teruaki Yamauchi, et al.. (2000). Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. Journal of Clinical Investigation. 106(4). 541–550. 49 indexed citations
6.
Kuroki, Tatsuya, Toyoshi Inoguchi, Fumio Umeda, & Hajime Nawata. (1998). Effect of Eicosapentaenoic Acid on Glucose-Induced Diacylglycerol Synthesis in Cultured Bovine Aortic Endothelial Cells. Biochemical and Biophysical Research Communications. 247(2). 473–477. 18 indexed citations
7.
Ono, Yasuhiro, et al.. (1998). Reduced Expression of a Novel Peptide, Prostacyclin-Stimulating Factor, in the Kidneys of Streptozotocin-Induced Diabetic Rats. Journal of Diabetes and its Complications. 12(5). 252–258. 8 indexed citations
8.
Kunisaki, Makoto, Sven–Erik Bursell, Fumio Umeda, Hajime Nawata, & George L. King. (1998). Prevention of diabetes‐induced abnormal retinal blood flow by treatment with d‐α‐tocopherol. BioFactors. 7(1-2). 55–67. 24 indexed citations
9.
Ito, Hideki, Yutaka Harano, Masaaki Suzuki, et al.. (1996). Risk Factor Analyses for Macrovascular Complication in Nonobese NIDDM Patients: Multiclinical Study for Diabetic Macroangiopathy (MSDM). Diabetes. 45(Supplement_3). S19–S23. 33 indexed citations
10.
Umeda, Fumio. (1995). Potential Role of Thiazolidinediones in Older Diabetic Patients. Drugs & Aging. 7(5). 331–337. 5 indexed citations
11.
Umeda, Fumio, Tatsuya Kuroki, & Hajime Nawata. (1995). Prostaglandins and diabetic nephropathy. Journal of Diabetes and its Complications. 9(4). 334–336. 14 indexed citations
12.
Hiramatsu, Shinsuke, Kaoru Inoue, Yasuhiro Sako, Fumio Umeda, & Hajime Nawata. (1994). Insulin treatment improves relative hypersecretion of amylin to insulin in rats with non-insulin-dependent diabetes mellitus induced by neonatal streptozocin injection. Metabolism. 43(6). 766–770. 7 indexed citations
13.
Tajiri, Yuji, Fumio Umeda, Toyoshi Inoguchi, & Hajime Nawata. (1994). Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat. Journal of Diabetes and its Complications. 8(2). 126–132. 14 indexed citations
14.
Watanabe, Jun, Yasuhiro Sako, Fumio Umeda, & Hajime Nawata. (1993). Effects of cilostazol, a phosphodiesterase inhibitor, on urinary excretion of albumin and prostaglandins in non-insulin-dependent diabetic patients. Diabetes Research and Clinical Practice. 22(1). 53–59. 10 indexed citations
15.
Inoue, Kaoru, Shinsuke Hiramatsu, Akitaka Hisatomi, Fumio Umeda, & Hajime Nawata. (1993). Hypersecretion of amylin from the perfused pancreas of genetically obese ( ) rats and its alteration with aging. Metabolism. 42(5). 654–658. 10 indexed citations
16.
Ono, Hiroshi, Fumio Umeda, Toyoshi Inoguchi, & Hiroshi Ibayashi. (1989). Decrease in insulin binding to aortic endothelial cells cultured with high glucose concentration. Diabetes Research and Clinical Practice. 6(2). 115–119. 5 indexed citations
17.
Sako, Yasuhiro, Fumio Umeda, Toshihiko Hashimoto, et al.. (1988). Clinical efulness of Measurement of Serum Fructosamine in Diabetics: Influence of Renal Failure, Liver Cirrhosis, and Thyroid Dysfunction. 31(12). 929–935. 1 indexed citations
18.
Kunisaki, Makoto, Fumio Umeda, Toyoshi Inoguchi, Hiroshi Ono, & Yasuhiro Sako. (1988). Effect of Vitamin E on Prostacyclin Production from Cultured Aortic Endothelial Cells. Advances in experimental medicine and biology. 242. 113–117. 2 indexed citations
19.
Watanabe, Jun, Fumio Umeda, Hidekatsu Sugimoto, Taro Wasada, & Hiroshi Ibayashi. (1985). Decreased prostacyclin production and platelet abnormalities in diabetes mellitus.. 28(11). 1229–1234. 3 indexed citations
20.
Umeda, Fumio, Serge Adnot, Douglas J. Franks, & Pavel Hamet. (1982). Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats. Metabolism. 31(7). 704–709. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Fumelli Breakdown of academic impact, for papers by PP Nawroth Breakdown of academic impact, for papers by Thomas Quaschning Breakdown of academic impact, for papers by G L King Breakdown of academic impact, for papers by Teruaki Yamauchi Breakdown of academic impact, for papers by Noriko Takahara Breakdown of academic impact, for papers by Koji Kuboki Breakdown of academic impact, for papers by Sachiko Hattori Breakdown of academic impact, for papers by Domenico De Cesare Breakdown of academic impact, for papers by Antonio J. Cayatte
Rankless by CCL
2026